NHS Expenditure and EU Negotiations 2020-09-01
2020-09-01
TAGS
Response quality
Questions & Answers
Q1
Direct Answer
▸
Context
The UK is currently negotiating its future relationship with the EU post-transition period, which could affect NHS spending.
What recent assessment has been made regarding the potential effect on NHS expenditure due to ongoing negotiations with the EU? The hon. Member also inquired about customs bureaucracy leading to increased drug costs for the NHS, particularly for insulin that is not produced in the UK, and noted challenges faced by pharmaceutical firms in rebuilding stockpiles.
The Department is implementing a multi-layered approach to guarantee continuity of supply for medicines and medical products, regardless of the negotiation outcomes or the transition period end. We are assured that supply continuity will be maintained.
▸
Assessment & feedback
Response accuracy